Profile
Christopher Cummins was the founder of Nova Science Ltd.
where he held the title of Director-Research & Development.
Mr. Cummins is also the founder of Vasorum Ltd.
Christopher Cummins active positions
| Companies | Position | Start |
|---|---|---|
Vasorum Ltd.
 Vasorum Ltd. Medical SpecialtiesHealth Technology Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland. | Founder | - |
Former positions of Christopher Cummins
| Companies | Position | End |
|---|---|---|
Nova Science Ltd.
 Nova Science Ltd. BiotechnologyHealth Technology Nova Science Ltd. provides medical research and development services for the diagnostic, interventional cardiology, and radiology markets. The firm operates as a subsidiary of Abbott Laboratories. The company was founded by James E. Cole and Christopher Cumm in 1999 and is headquartered in Dublin, Ireland. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Nova Science Ltd.
Nova Science Ltd. BiotechnologyHealth Technology Nova Science Ltd. provides medical research and development services for the diagnostic, interventional cardiology, and radiology markets. The firm operates as a subsidiary of Abbott Laboratories. The company was founded by James E. Cole and Christopher Cumm in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
Vasorum Ltd.
Vasorum Ltd. Medical SpecialtiesHealth Technology Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland. | Health Technology |
- Stock Market
- Insiders
- Christopher Cummins
